| The cost of COPD exacerbations: a university hospital–based study in Greece M Geitona, M Hatzikou, P Steiropoulos, EC Alexopoulos, D Bouros Respiratory medicine 105 (3), 402-409, 2011 | 68 | 2011 |
| The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study) G Rombopoulos, M Hatzikou, D Latsou, J Yfantopoulos Hormones 12 (4), 550-558, 2013 | 51 | 2013 |
| Generics market in Greece: the pharmaceutical industry's beliefs M Geitona, D Zavras, M Hatzikou, J Kyriopoulos Health Policy 79 (1), 35-48, 2006 | 42 | 2006 |
| Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece N Maniadakis, N Tzanakis, V Fragoulakis, M Hatzikou, N Siafakas Current medical research and opinion 22 (8), 1599-1607, 2006 | 39 | 2006 |
| Economic evaluation of treatment strategies for patients suffering acute myocardial infarction in Greece N Maniadakis, D Kaitelidou, O Siskou, M Spinthouri, L Liaropoulos, ... Hellenic J Cardiol 46 (3), 212-221, 2005 | 30 | 2005 |
| The cost of managing type 2 diabetes mellitus in Greece: a retrospective analysis of 10-year patient level data “The HERCULES Study” I Migdalis, G Rombopoulos, M Hatzikou, C Manes, N Kypraios, ... International journal of endocrinology 2015, 2015 | 25 | 2015 |
| The economic burden of treating neonates in Intensive Care Units (ICUs) in Greece M Geitona, M Hatzikou, Z Hatzistamatiou, A Anastasiadou, ... Cost effectiveness and resource allocation 5, 1-7, 2007 | 24 | 2007 |
| Treatment compliance with fixed-dose combination of vildagliptin/metformin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: a 24 … G Rombopoulos, M Hatzikou, A Athanasiadis, M Elisaf International Journal of Endocrinology 2015, 2015 | 21 | 2015 |
| Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries M Kamusheva, M Manova, AT Savova, GI Petrova, K Mitov, A Harsányi, ... Frontiers in pharmacology 9, 795, 2018 | 17 | 2018 |
| Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components P Stafylas, G Kourlaba, M Hatzikou, D Georgiopoulos, P Sarafidis, ... Cost Effectiveness and Resource Allocation 13, 1-11, 2015 | 15 | 2015 |
| Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece H Kousoulakou, M Hatzikou, V Baroutsou, J Yfantopoulos Cost Effectiveness and Resource Allocation 15, 1-7, 2017 | 14 | 2017 |
| Budget impact analysis on erythropoiesis–stimulating agents use for the management of chemotherapy-induced anaemia in Greece E Nikolaidi, M Hatzikou, M Geitona Cost Effectiveness and Resource Allocation 11, 1-7, 2013 | 9 | 2013 |
| Health and economic impact of relapsing forms of multiple sclerosis in Greece: the storms study J Yfantopoulos, N Grigoriadis, I Iliopoulos, K Karageorgiou, A Chantzaras, ... Pharmacoeconomics 1 (10), 10.4172, 2015 | 7 | 2015 |
| Cost estimation of neonatal intensive care in Greece: the case of Athens maternity hospitals M Geitona, M Hatzikou Journal of Medical Economics 10 (3), 273-283, 2007 | 6 | 2007 |
| Treatment pathways and associated costs of metastatic colorectal cancer in Greece I Sougklakos, E Athanasiadis, I Boukovinas, M Karamouzis, A Koutras, ... Cost Effectiveness and Resource Allocation 20 (1), 7, 2022 | 4 | 2022 |
| Economic evaluation of omalizumab compared with standard therapy in the treatment of severe allergic asthma in adult patients in Greece: a cost effectiveness analysis based on … V Sonathi, M Hatzikou, M Baldwin, E Panitti, E Tzortzaki Value in Health 17 (7), A597-A598, 2014 | 4 | 2014 |
| PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help? C Kani, P Litsa, E Alexopoulou, M Hatzikou, S Delibasi, M Geitona Value in Health 14 (7), A412-A413, 2011 | 4 | 2011 |
| PRS35 economic evaluation of indacaterol versus tiotropium or formoterol for patients with moderate to severe Copd in Greece M Geitona, M Hatzikou, E Bania Value in Health 14 (7), A493, 2011 | 4 | 2011 |
| The prevalence of hypoglycemia and its impact on the quality of life of type 2 diabetes mellitus patients in Greece (the Hypo study) J Yfantopoulos, M Hatzikou, G Rombopoulos, E Panitti, D Latsou Value in Health 17 (7), A356, 2014 | 3 | 2014 |
| PDB43 economic evaluation of vildagliptin compared to glimepiride as add-on to metformin for the treatment of diabetes mellitus type 2 patients in Greece M Hatzikou, G Rombopoulos, J Yfantopoulos Value in Health 15 (7), A501, 2012 | 3 | 2012 |
Mary GeitonaProfessor University of PeloponneseVerified email at uop.gr
